Pharmaceuticals

Lupin’s sleep disorder drug gets USFDA nod

22 Mar 2010

Panacea Bio wins Rs10 crore government aid for developing swine flu vaccine

22 Mar 2010

India's pharma exports record CAGR of 21.25 per cent in FY'07-FY'09

20 Mar 2010

Strides Arcolab acquires SA firm Aspen's stake in two joint ventures

19 Mar 2010

Further expansion of branded generics, OTC and dermatology portfolio

19 Mar 2010

Teva to acquire Germany's Ratiopharm for $5 billion

18 Mar 2010

The acquisition will position Teva as the leading generic pharmaceutical company in Europe

Glenmark receives FDA approval for Moexipril Hydrochloride tablets

18 Mar 2010

Sun Pharma gets USFDA approval for generic Prometh syrup

18 Mar 2010

GVK Biosciences opens new clinical pharmacology unit in Ahmedabad

17 Mar 2010

Strides Arcolab to delist Aussie subsidiary Ascent Pharmahealth by acquiring publicly held shares

17 Mar 2010

OSI Pharmaceuticals rejects Astellas $3.5-billion hostile bid

17 Mar 2010

Boston Scientific suspends sales of seven defibrillators

17 Mar 2010

Boston Scientific said that it has identified two instances of process changes that, while successfully validated, were not submitted to the FDA for approval

Eli Lilly inks $335 million licensing deal with Australia’s Acrux

17 Mar 2010

Sigma-Aldrich to sell Pfizer's bioactive small molecule compounds

15 Mar 2010

MCI all set to amend Medical Ethics Regulations

13 Mar 2010

Sanofi-Aventis concludes Chattem acquisition

13 Mar 2010

Battelle, IBM, Merck join UPMC’s effort to produce vaccines

12 Mar 2010

Torrent in AstraZeneca's debut deal to sell branded generics

11 Mar 2010

In its first ever deal with a generics manufacturer AstraZeneca will brand and sell Ahmedabad-based Torrent Pharma's generic drugs in emerging markets.

FDA grants "orphan drug" status to Bayer's Ciprofloxacin dry powder inhaler for cystic fibrosis

11 Mar 2010

Abbott receives US FDA approval for new cataract multifocal intraocular lens

11 Mar 2010

Abbott Laboratories to acquire Facet Biotech for $450 million

10 Mar 2010

GlaxoSmithKline on the prowl for acquisitions in India

09 Mar 2010

Eli Lilly’s Elanco takes over Pfizer’s European animal health portfolio

09 Mar 2010

Strides Arcolab buys back divested Brazillian facility from Aspen for $75 million

By Ravi Kunder | 05 Mar 2010

Strides Arcolabs had sold its 51-per cent stake in Strides Latina to Aspen for $152 million in 2007, and is now reacquiring it at half the price, reports Ravi Kunder

Astellas sues OSI Pharmaceuticals for adopting poison pill tactics

04 Mar 2010